S100a8/a9 elicits powerful anti-tumor responses and induces cell death program or apoptosis, which appears to be independent of death receptors like the Receptor of Advanced Glycation Endproducts or Fas-associated with death domain protein[2]. Here, IGKV1D-22 is linked to neoplasm.